We studied the effects of 6 common antidiabetic drugs on tumor inhibition of anti-PD1 immune checkpoint inhibitor, including acarbose, sitagliptin, metformin, glimepiride, pioglitazone, and insulin. Here, INS is linked to neoplasm.